Roche Holding AG (LON:0QOK)

London flag London · Delayed Price · Currency is GBP · Price in CHF
313.59
+0.34 (0.11%)
At close: Dec 3, 2025
22.41%
Market Cap 248.01B
Revenue (ttm) 58.27B
Net Income (ttm) 8.65B
Shares Out n/a
EPS (ttm) 10.78
PE Ratio 28.66
Forward PE 16.36
Dividend 8.49 (2.71%)
Ex-Dividend Date Mar 27, 2025
Volume 591,892
Average Volume 422,578
Open 313.50
Previous Close 313.25
Day's Range 312.50 - 318.90
52-Week Range 221.30 - 316.20
Beta 0.17
RSI 65.23
Earnings Date Jan 29, 2026

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagn... [Read more]

Industry Pharmaceutical Preparations
Founded 1896
Employees 103,249
Stock Exchange London Stock Exchange
Ticker Symbol 0QOK
Full Company Profile

Financial Performance

In 2024, Roche Holding AG's revenue was 62.40 billion, an increase of 3.23% compared to the previous year's 60.44 billion. Earnings were 8.28 billion, a decrease of -28.01%.

Financial numbers in CHF Financial Statements

News

There is no news available yet.